Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 0 | 0 | 113 | 0 | 0 |
| Cost of Goods | N/A | N/A | 113 | N/A | N/A |
| Operating Expenses | 49,187 | 35,730 | 39,362 | 33,692 | 26,429 |
| Operating Income | -49,187 | -35,730 | -39,249 | -33,692 | -26,429 |
| Other Income | 296 | 596 | 383 | 329 | 264 |
| Pre-tax Income | -48,891 | -35,134 | -38,866 | -33,363 | -26,165 |
| Net Income Continuous | -48,891 | -35,134 | -38,866 | -33,363 | -26,165 |
| Net Income | $-48,891 | $-35,134 | $-38,866 | $-33,363 | $-26,165 |
| EPS Basic Total Ops | -0.98 | -0.70 | -0.79 | -0.76 | -0.63 |
| EPS Basic Continuous Ops | -0.98 | -0.70 | -0.79 | -0.76 | -0.63 |
| EPS Diluted Total Ops | -0.98 | -0.70 | -0.79 | -0.76 | -0.63 |
| EPS Diluted Continuous Ops | -0.98 | -0.70 | -0.79 | -0.76 | -0.63 |
| EBITDA(a) | $-48,527 | $-35,221 | $-38,979 | $-33,457 | $-26,249 |